Q4 Results in...and its not good.

Discussion in 'KCI' started by Anonymous, Mar 10, 2014 at 3:38 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Revenue:
    Rental $ 180,803
    $ 199,851
    (9.5 )% $ 750,252
    $ 822,201
    (8.8 )%
    Sales 288,984
    240,081
    20.4
    1,008,659
    924,252
    9.1

    Total revenue 469,787
    439,932
    6.8
    1,758,911
    1,746,453
    0.7


    Rental expenses 85,116
    95,059
    (10.5 ) 358,595
    443,446
    (19.1 )
    Cost of sales 79,862
    58,884
    35.6
    261,569
    249,338
    4.9

    Gross profit 304,809
    285,989
    6.6
    1,138,747
    1,053,669
    8.1


    Selling, general and administrative expenses 177,697
    157,000
    13.2
    696,175
    602,781
    15.5

    Research and development expenses 19,484
    18,173
    7.2
    75,624
    71,859
    5.2

    Acquired intangible asset amortization 49,448
    48,724
    1.5
    188,571
    220,984
    (14.7 )
    Impairment of goodwill and intangible assets —


    443,400



    Operating earnings (loss) 58,180
    62,092
    (6.3 ) (265,023 ) 158,045



    Interest income and other 323
    199
    62.3
    1,602
    829
    93.2

    Interest expense (104,733 ) (113,515 ) (7.7 ) (419,877 ) (466,622 ) (10.0 )
    Loss on extinguishment of debt —
    (31,481 ) —
    (2,364 ) (31,481 ) (92.5 )
    Foreign currency loss (10,291 ) (13,429 ) (23.4 ) (22,226 ) (13,001 ) 71.0

    Derivative instruments gain (loss) (1,624 ) (2,960 ) (45.1 ) 1,576
    (31,433 ) —

    Loss from continuing operations before income tax benefit (58,145 ) (99,094 ) (41.3 ) (706,312 ) (383,663 ) 84.1

    Income tax benefit (6,414 ) (42,923 ) (85.1 ) (150,957 ) (150,048 ) 0.6

    Loss from continuing operations (51,731 ) (56,171 ) (7.9 ) (555,355 ) (233,615 ) 137.7

    Gain (loss) from discontinued operations, net of tax (1,004 ) 95,878

    (3,303 ) 92,198


    Net earnings (loss) $ (52,735 ) $ 39,707
    — % $ (558,658 ) $ (141,417 ) — %
     

  2. Anonymous

    Anonymous Guest

    And there's the cost of treating your employees and your customers like shit. In the end it'll be the deplorable retention rate in sales and the loss of intellectual property across the board with every layoff that will take its toll. The saddest thing is that it's entirely self inflicted by some of the biggest morons to line a boardroom ... Total maggots.
     
  3. Anonymous

    Anonymous Guest

    Hello resume
     
  4. Anonymous

    Anonymous Guest

    wtf does this company sell? suction and foam? uhhhh, a hickey proves suction promotes perfusion. You guys should be happy with what you have achieved over the last few decades. You swindled payors out of billions. Let it go. All you are doing is prolonging the inevitable. You sell a commodity, dipshits.
     
  5. Anonymous

    Anonymous Guest

    ding ding ding ding. and with the addition of systagenix this company is now one large turd covered with extra turd juice. you think losses are big now wait until they think systagenix two main products will grow by 200% next year. Keep reminding yourselves why JNJ pinched this loaf off. It was a turd.
     
  6. Anonymous

    Anonymous Guest

    And what do you sell? Please tell me.
     
  7. Anonymous

    Anonymous Guest

    “My enthusiasm and confidence in this business has never been higher,” President and CEO Joe Woody said on a conference call with analysts Thursday.
     
  8. Anonymous

    Anonymous Guest

    "We continue to take market share, reimbursement has never been better, we do not see any new competition, we have hundreds of studies that show the Wound VAC is more effective than any other system on the market and customers cuntinue to tell us how well we treat them....oh and thank you for the $1million plus in compensation and dont worry about my nose getting longer"
     
  9. Anonymous

    Anonymous Guest

    Spot on...what a liar JW is saying hes never been more enthusiastic. Do something to stop the decline. I guess if he makes it three years at that compensation plus a nice buyout when he fails is worth the lies.
     
  10. Anonymous

    Anonymous Guest

    We have nowhere to go but down.. We had 100% of the market until Smith&Nephew, Medela, Galaxy, Molnlycke, etc came into the market. We will do nothing but lose share even if we are the best. Someone will look for financial savings and even if we keep the account, it will be worth less. This company and this job sucks and I want out!!
     
  11. Anonymous

    Anonymous Guest

    Anyone that believes this dribble is delusional and needs an analyst. I guess if JW says it often enough he will start to believe it. Where are they hiding this guy anyway ?
     
  12. Anonymous

    Anonymous Guest

    Now Q1 is below performance..................... Lifecell small growth and Systegenix decent growth......us...Negative. If it was not for the other 2 divisions we would be in bigger trouble.